Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G CLELAND

Showing results (391-400 of 663) with videos related to

Pageof 67
Sort By:
The Journal of Rheumatology|October 1, 1988
Clinical and biochemical effects of dietary fish oil supplements in rheumatoid arthritisL G Cleland, J K French, W H Betts, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1990
IL-3 and granulocyte-macrophage colony-stimulating factor stimulate two distinct phases of adhesion in human monocytesM J Elliott, M A Vadas, L G Cleland, et al.
International Journal of Cardiology|July 6, 2011
Identifying patients at risk of death or hospitalisation due to worsening heart failure using decision tree analysis: evidence from the Trans-European Network-Home-Care Management System (TEN-HMS) studyJufen Zhang, Kevin M Goode, Alan Rigby, et al.
The American Journal of Cardiology|June 1, 1996
Effects of aging on neuroendocrine activation in subjects and patients in the presence and absence of heart failure with left ventricular systolic dysfunctionD P Dutka, I Olivotto, S Ward, et al.
Lipids|October 1, 1995
Differences in fatty acid composition of immature and mature articular cartilage in humans and sheepK A Cleland, M J James, M A Neumann, et al.
European Heart Journal|November 1, 1996
Beta-blocking agents in heart failure. Should they be used and how?J G Cleland, M R Bristow, E Erdmann, et al.
Biochimica Et Biophysica Acta|June 5, 1992
Incorporation of dietary oleate, linoleate, alpha-linolenate and eicosapentaenoate into the plasma lipid fractions of four strains of ratR A Gibson, M J James, M A Neumann, et al.
European Journal of Heart Failure|May 30, 2001
Clinical Trials Update: CAPRICORN, COPERNICUS, MIRACLE, STAF, RITZ-2, RECOVER and RENAISSANCE and cachexia and cholesterol in heart failure. Highlights of the Scientific Sessions of the American College of Cardiology, 2001A Louis, J G Cleland, S Crabbe, et al.
The Journal of Infection|January 1, 1986
Sequential bacteriological findings in the cerebrospinal fluid of Nigerian patients with pneumococcal meningitisB M Greenwood, M Hassan-King, P G Cleland, et al.
European Journal of Heart Failure|February 13, 2001
Clinical trials update: highlights of the scientific sessions of the American Heart Association year 2000: Val HeFT, COPERNICUS, MERIT, CIBIS-II, BEST, AMIOVIRT, V-MAC, BREATHE, HEAT, MIRACL, FLORIDA, VIVA and the first human cardiac skeletal muscle myoblast transfer for heart failureS D Thackray, K K Witte, A Khand, et al.
Pageof 67

Showing results (391-400 of 663) with videos related to

Sort By:
Pageof 67
The Journal of Rheumatology|October 1, 1988
Clinical and biochemical effects of dietary fish oil supplements in rheumatoid arthritisL G Cleland, J K French, W H Betts, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1990
IL-3 and granulocyte-macrophage colony-stimulating factor stimulate two distinct phases of adhesion in human monocytesM J Elliott, M A Vadas, L G Cleland, et al.
International Journal of Cardiology|July 6, 2011
Identifying patients at risk of death or hospitalisation due to worsening heart failure using decision tree analysis: evidence from the Trans-European Network-Home-Care Management System (TEN-HMS) studyJufen Zhang, Kevin M Goode, Alan Rigby, et al.
The American Journal of Cardiology|June 1, 1996
Effects of aging on neuroendocrine activation in subjects and patients in the presence and absence of heart failure with left ventricular systolic dysfunctionD P Dutka, I Olivotto, S Ward, et al.
Lipids|October 1, 1995
Differences in fatty acid composition of immature and mature articular cartilage in humans and sheepK A Cleland, M J James, M A Neumann, et al.
European Heart Journal|November 1, 1996
Beta-blocking agents in heart failure. Should they be used and how?J G Cleland, M R Bristow, E Erdmann, et al.
Biochimica Et Biophysica Acta|June 5, 1992
Incorporation of dietary oleate, linoleate, alpha-linolenate and eicosapentaenoate into the plasma lipid fractions of four strains of ratR A Gibson, M J James, M A Neumann, et al.
European Journal of Heart Failure|May 30, 2001
Clinical Trials Update: CAPRICORN, COPERNICUS, MIRACLE, STAF, RITZ-2, RECOVER and RENAISSANCE and cachexia and cholesterol in heart failure. Highlights of the Scientific Sessions of the American College of Cardiology, 2001A Louis, J G Cleland, S Crabbe, et al.
The Journal of Infection|January 1, 1986
Sequential bacteriological findings in the cerebrospinal fluid of Nigerian patients with pneumococcal meningitisB M Greenwood, M Hassan-King, P G Cleland, et al.
European Journal of Heart Failure|February 13, 2001
Clinical trials update: highlights of the scientific sessions of the American Heart Association year 2000: Val HeFT, COPERNICUS, MERIT, CIBIS-II, BEST, AMIOVIRT, V-MAC, BREATHE, HEAT, MIRACL, FLORIDA, VIVA and the first human cardiac skeletal muscle myoblast transfer for heart failureS D Thackray, K K Witte, A Khand, et al.
Pageof 67